Matches in Wikidata for { <http://www.wikidata.org/entity/Q64030232> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q64030232 description "clinical trial" @default.
- Q64030232 description "ensayu clínicu" @default.
- Q64030232 description "klinisch onderzoek" @default.
- Q64030232 description "клінічне випробування" @default.
- Q64030232 description "կլինիկական փորձարկում" @default.
- Q64030232 name "Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes" @default.
- Q64030232 type Item @default.
- Q64030232 label "Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes" @default.
- Q64030232 prefLabel "Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes" @default.
- Q64030232 P1050 Q64030232-81BFC3E5-E51F-4A4A-92E8-AFFE9DD16E90 @default.
- Q64030232 P1132 Q64030232-DF677F0C-F69C-4DD4-92ED-6980E3662516 @default.
- Q64030232 P131 Q64030232-1D02BEC7-6EF8-4F86-8EC8-BDF3BCA04BB4 @default.
- Q64030232 P1476 Q64030232-8199F26B-B683-40C1-A91E-F421A1FF639F @default.
- Q64030232 P17 Q64030232-24EC0818-1363-447B-96D7-5BDFE049E802 @default.
- Q64030232 P17 Q64030232-3822D0F0-94C4-4220-B449-3C97D6D1D682 @default.
- Q64030232 P17 Q64030232-76322B56-D3D7-4622-95C5-001D646F94A0 @default.
- Q64030232 P17 Q64030232-8F4A7E87-3FB7-42FB-9E57-3F13CB590BC7 @default.
- Q64030232 P17 Q64030232-D9BBD860-F1D4-4B5C-B991-29B5AC1CA5FA @default.
- Q64030232 P17 Q64030232-DF1807C1-919C-4EF5-97D0-3F57E7E1B59A @default.
- Q64030232 P2899 Q64030232-644B482B-2875-42C7-8F28-3751A9940232 @default.
- Q64030232 P3098 Q64030232-0D446333-29FE-47B2-B916-DA4CC8EDD07B @default.
- Q64030232 P31 Q64030232-8882E1DD-802C-4A20-AD8A-F4276291D9B8 @default.
- Q64030232 P4844 Q64030232-2D3E830C-E1F0-49F4-B74D-E7F67592653A @default.
- Q64030232 P580 Q64030232-429D2F89-8C59-4F8F-B4F7-31F94D684B43 @default.
- Q64030232 P582 Q64030232-8411D90A-D03A-43FA-8239-3C5608AB5770 @default.
- Q64030232 P6099 Q64030232-D7550B2C-BF16-40F0-A04E-0DED7D0BB64D @default.
- Q64030232 P6153 Q64030232-F5753455-1201-44CB-A38A-D6411467613A @default.
- Q64030232 P8363 Q64030232-CA715ACB-7493-48E8-B9EE-DF4C76EEBDA3 @default.
- Q64030232 P1050 Q12206 @default.
- Q64030232 P1132 "+320" @default.
- Q64030232 P131 Q1183 @default.
- Q64030232 P1476 "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Therapy With Dapagliflozin Added to Saxagliptin in Combination With Metformin Compared to Therapy With Placebo Added to Saxagliptin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin and Saxagliptin" @default.
- Q64030232 P17 Q145 @default.
- Q64030232 P17 Q213 @default.
- Q64030232 P17 Q218 @default.
- Q64030232 P17 Q30 @default.
- Q64030232 P17 Q36 @default.
- Q64030232 P17 Q96 @default.
- Q64030232 P2899 "+18" @default.
- Q64030232 P3098 "NCT01646320" @default.
- Q64030232 P31 Q30612 @default.
- Q64030232 P4844 Q19484 @default.
- Q64030232 P580 "2012-09-01T00:00:00Z" @default.
- Q64030232 P582 "2014-08-01T00:00:00Z" @default.
- Q64030232 P6099 Q42824827 @default.
- Q64030232 P6153 Q1472663 @default.
- Q64030232 P8363 Q78089383 @default.